BIOPHARMA DEVELOPMENT AI BY BCG X Trademark

Trademark Overview


On Monday, December 23, 2024, a trademark application was filed for BIOPHARMA DEVELOPMENT AI BY BCG X with the United States Patent and Trademark Office. The USPTO has given the BIOPHARMA DEVELOPMENT AI BY BCG X trademark a serial number of 98919023. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 23, 2024. This trademark is owned by The Boston Consulting Group, Inc.. The BIOPHARMA DEVELOPMENT AI BY BCG X trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and advisory services related to planning and conducting clinical trials and analyzing clinical trial data; business consulting and management in the field of clinical trials, namely, advising companies on clinical trial methods and processes for business optimization purposes; providing information and advice about best practices for planning and conducting clinical trials, and associated methodologies and processes for business process optimization purposes; providing businesses with best practices, methodologies, rankings, and evaluations in the field of clinical trials; providing business project management consulting services, namely, predicting project outcomes and modifying project implementation to increase likelihood of success in business transformation projects

Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials
biopharma development ai by bcg x

General Information


Serial Number98919023
Word MarkBIOPHARMA DEVELOPMENT AI BY BCG X
Filing DateMonday, December 23, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, December 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stacked words "BIOPHARMA , above "DEVELOPMENT AI", which is, in turn, above "BY BCG X", all to the right a box design containing a circle and two arcs.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBusiness consulting and advisory services related to planning and conducting clinical trials and analyzing clinical trial data; business consulting and management in the field of clinical trials, namely, advising companies on clinical trial methods and processes for business optimization purposes; providing information and advice about best practices for planning and conducting clinical trials, and associated methodologies and processes for business process optimization purposes; providing businesses with best practices, methodologies, rankings, and evaluations in the field of clinical trials; providing business project management consulting services, namely, predicting project outcomes and modifying project implementation to increase likelihood of success in business transformation projects
Goods and ServicesProviding temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable generative AI software to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technical consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, December 23, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameThe Boston Consulting Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Monday, December 23, 2024NEW APPLICATION ENTERED